Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALBO | BMY | AMGN | MRNA | GILD |
| Company | Albireo Pharma Inc | Bristol-Myers Squibb Company | Amgen Inc | Moderna Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 44.90 | 49.89 | 337.03 | 71.85 | 84.39 |
| High | 44.90 | 50.04 | 338.70 | 71.97 | 84.65 |
| Low | 43.99 | 48.94 | 334.61 | 67.91 | 83.43 |
| Last | 44.15 | 49.02 | 335.95 | 68.02 | 83.90 |
| Change | -0.10 | -0.72 | +3.03 | -1.84 | +0.01 |
| % Change | -0.23% | -1.45% | +0.91% | -2.63% | +0.01% |
| Volume | 1,241,200 | 8,841,400 | 1,626,200 | 5,065,400 | 8,798,200 |
| 20-Day Average Volume | 635,260 | 8,610,180 | 1,760,685 | 5,526,845 | 6,694,930 |
| Previous Close | 44.25 | 49.74 | 332.92 | 69.86 | 83.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 44.18 | 49.09 | 329.59 | 75.08 | 80.07 |
| 20-Day Raw Stochastic | 43.90% | 55.24% | 84.75% | 17.23% | 89.62% |
| 20-Day Relative Strength | 72.09% | 54.18% | 57.67% | 32.30% | 71.87% |
| Weighted Alpha | +16.30 | -11.20 | +27.09 | -35.75 | +18.24 |
| Today's Opinion | 88% Buy | 56% Buy | 96% Buy | 88% Sell | 88% Buy |
| Previous Opinion | 100% Buy | 72% Buy | 88% Buy | 88% Sell | 88% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Buy | 56% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.28% since 02/23/23 | +1.62% since 09/12/24 | +1.78% since 09/12/24 | -2.38% since 09/12/24 | +0.89% since 09/12/24 |
| Low | 43.53 on 02/24/23 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 65.55 on 09/13/24 | 81.57 on 09/13/24 |
| High | 44.90 on 03/02/23 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 75.37 on 09/17/24 | 84.65 on 09/19/24 |
| 1-Month | |||||
| %Chg | -0.90% since 02/02/23 | -0.57% since 08/19/24 | +2.43% since 08/19/24 | -24.39% since 08/19/24 | +12.69% since 08/19/24 |
| Low | 43.31 on 02/23/23 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 64.11 on 09/12/24 | 74.34 on 08/20/24 |
| High | 45.23 on 02/03/23 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 89.80 on 08/20/24 | 84.89 on 09/12/24 |
| 3-Month | |||||
| %Chg | +85.66% since 12/02/22 | +20.12% since 06/18/24 | +9.79% since 06/18/24 | -48.96% since 06/18/24 | +32.86% since 06/18/24 |
| Low | 17.78 on 12/27/22 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.11 on 09/12/24 | 64.86 on 06/20/24 |
| High | 45.23 on 02/03/23 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 138.07 on 06/25/24 | 84.89 on 09/12/24 |
| 6-Month | |||||
| %Chg | +156.84% since 09/02/22 | -5.37% since 03/19/24 | +23.63% since 03/19/24 | -35.29% since 03/19/24 | +14.29% since 03/19/24 |
| Low | 16.02 on 09/07/22 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 64.11 on 09/12/24 | 62.07 on 05/31/24 |
| High | 45.23 on 02/03/23 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 170.47 on 05/24/24 | 84.89 on 09/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 913,949 | 99,368,440 | 180,215,344 | 26,067,982 | 104,527,072 |
| Shares Outstanding, K | 20,701 | 2,027,100 | 536,435 | 383,240 | 1,245,853 |
| Annual Sales | 40,580,000 | 45,006,000,000 | 28,190,000,000 | 6,848,000,000 | 27,116,000,000 |
| Annual Net Income | -34,030,000 | 8,025,000,000 | 6,717,000,000 | -4,714,000,000 | 5,665,000,000 |
| Last Quarter Sales | 9,830,000 | 12,201,000,000 | 8,388,000,000 | 241,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -37,800,000 | 1,680,000,000 | 746,000,000 | -1,279,000,000 | 1,614,000,000 |
| 60-Month Beta | 1.03 | 0.46 | 0.61 | 1.67 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/08/22 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | -3.33 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 03/07/23 | 10/31/24 | 10/29/24 | 11/07/24 | 11/05/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.31 | 17.90 | 0.00 | 17.85 |